Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.120
-0.040 (-1.85%)
At close: Apr 28, 2026, 4:00 PM EDT
2.120
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:46 PM EDT
Protalix BioTherapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Protalix BioTherapeutics stock has a target of 12, which predicts an increase of 466.04% from the current stock price of 2.12.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 19, 2026.
Analyst Ratings
According to 1 stock analyst, the rating for Protalix BioTherapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +466.04% | Mar 19, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $12 | Strong Buy | Maintains | $15 → $12 | +466.04% | Nov 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $15 | Strong Buy | Maintains | $10 → $15 | +607.55% | Feb 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +371.70% | Nov 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +371.70% | Oct 31, 2023 |
Financial Forecast
Revenue This Year
72.16M
from 52.74M
Increased by 36.81%
Revenue Next Year
69.73M
from 72.16M
Decreased by -3.36%
EPS This Year
0.07
from -0.08
EPS Next Year
0.11
from 0.07
Increased by 57.14%
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 82.4M | 79.9M |
| Avg | 72.2M | 69.7M |
| Low | 63.2M | 60.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 56.2% | 10.7% |
| Avg | 36.8% | -3.4% |
| Low | 19.8% | -15.8% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 0.21 | 0.15 |
| Avg | 0.07 | 0.11 |
| Low | -0.06 | 0.08 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | 107.9% |
| Avg | - | 57.1% |
| Low | - | 10.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.